Skip to main content
Erschienen in: Odontology 1/2016

01.01.2016 | Case Report

Anti-BP180-type mucous membrane pemphigoid: report of two cases

verfasst von: Mayumi Wada, Jun Sato, Masanobu Shindoh, Hideyuki Ujiie, Ken Natsuga, Wataru Nishie, Hiroshi Shimizu, Yoshimasa Kitagawa

Erschienen in: Odontology | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

We describe two patients with anti-BP180-type mucous membrane pemphigoid (MMP), who were correctly diagnosed and treated in early stages through the cooperation of dentists and dermatologists. Patient 1 was a 74-year-old woman who visited our dental department due to blisters over the oral mucosa and eruptions on the skin. She had also experienced bleeding of the gingiva and palate mucosa. Biopsy specimens from the oral mucosa revealed detachment of epithelial basement membrane and subepithelial lamina propria with slight chronic inflammation. Direct immunofluorescence (DIF) revealed linear IgG and IgA deposits along the basement membrane zone (BMZ). Indirect immunofluorescence (IIF) using 1 M-NaCl split normal human skin showed binding of IgG and IgA on the epidermal side. On immunoblot analysis, IgG and IgA autoantibodies reacted with the C-terminal protein of BP180. These findings indicated a diagnosis of anti-BP180-type MMP. Patient 2 was a 59-year-old woman who was referred to our dental department with a history of blisters and large erosions on the gingiva. Biopsy specimens from the oral mucosa revealed partial junctional separation at the level of the basement membrane. DIF showed linear depositions of IgG and C3 along the BMZ. IIF, using 1 M-NaCl split normal human skin, revealed circulating anti-BMZ-IgG antibodies bound to the epidermal side. These findings indicated a diagnosis of anti-BP180-type MMP. Both patients were treated successfully with systemic or topical steroids and oral health care. In conclusion, appropriate clinical examination and cooperation among medical specialists are important for the early diagnosis and treatment of patients with recurrent and chronic stomatitis and for their good prognosis.
Literatur
1.
Zurück zum Zitat Chan LS, Ahmed AR, Anhalt GJ, Bernauer W, Cooper KD, Elder MJ, Fine JD, Foster CS, Ghohestani R, Hashimoto T, Hoang-Xuan T, Kirtsching G, Korman NJ, Lightman S, Lozada-Nur F, Marinkovich MP, Mondino BJ, Prost-Squarcioni C, Rogers RS III, Setterfield JF, West DP, Wojnarowska F, Woodley DT, Yancey KB, Zillikens D, Zone JJ. The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol. 2002;138:370–9.PubMed Chan LS, Ahmed AR, Anhalt GJ, Bernauer W, Cooper KD, Elder MJ, Fine JD, Foster CS, Ghohestani R, Hashimoto T, Hoang-Xuan T, Kirtsching G, Korman NJ, Lightman S, Lozada-Nur F, Marinkovich MP, Mondino BJ, Prost-Squarcioni C, Rogers RS III, Setterfield JF, West DP, Wojnarowska F, Woodley DT, Yancey KB, Zillikens D, Zone JJ. The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol. 2002;138:370–9.PubMed
2.
Zurück zum Zitat Choi Y, Lee SE, Fukuda S, Hashimoto T, Kim SC. Mucous membrane pemphigoid with immunoglobulin G autoantibodies against full-length and 120-kDa ectodomain of BP180. J Dermatol. 2011;38:169–72.PubMedCrossRef Choi Y, Lee SE, Fukuda S, Hashimoto T, Kim SC. Mucous membrane pemphigoid with immunoglobulin G autoantibodies against full-length and 120-kDa ectodomain of BP180. J Dermatol. 2011;38:169–72.PubMedCrossRef
3.
Zurück zum Zitat Carrozzo M, Dametto E, Fasano ME, Broccoletti R, Carbone M, Rendine S, Amoroso A. Interleukin-4RA gene polymorphism is associated with oral mucous membrane pemphigoid. Oral Dis. 2014;20:275–80.PubMedCrossRef Carrozzo M, Dametto E, Fasano ME, Broccoletti R, Carbone M, Rendine S, Amoroso A. Interleukin-4RA gene polymorphism is associated with oral mucous membrane pemphigoid. Oral Dis. 2014;20:275–80.PubMedCrossRef
4.
Zurück zum Zitat Scully C. Lo Muzio L. Oral mucosal diseases. Mucous membrane pemphigoid. Br J Oral Maxillofac Surg. 2008;46:358–66.PubMedCrossRef Scully C. Lo Muzio L. Oral mucosal diseases. Mucous membrane pemphigoid. Br J Oral Maxillofac Surg. 2008;46:358–66.PubMedCrossRef
5.
Zurück zum Zitat Parisi E, Raghavendra S, Werth VP, Sollecito TP. Modification to the approach of the diagnosis of mucous membrane pemphigoid: a case report and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;95:182–6.PubMedCrossRef Parisi E, Raghavendra S, Werth VP, Sollecito TP. Modification to the approach of the diagnosis of mucous membrane pemphigoid: a case report and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;95:182–6.PubMedCrossRef
6.
Zurück zum Zitat Hayakawa T, Furumura M, Fukano H, Li X, Ishii N, Hamada T, Ohta C, Tsuruta D, Shimozato K, Hashimoto T. Diagnosis of mucous membrane pemphigoid of combined serologic testing. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117:483–96.PubMedCrossRef Hayakawa T, Furumura M, Fukano H, Li X, Ishii N, Hamada T, Ohta C, Tsuruta D, Shimozato K, Hashimoto T. Diagnosis of mucous membrane pemphigoid of combined serologic testing. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117:483–96.PubMedCrossRef
7.
Zurück zum Zitat Miyamoto S, Kaneko T, Sakaguchi W, Yasuda T, Chikazu D. A case of anti-BP180-type mucous membrane pemphigoid difficult to distinguish from bullous pemphigoid. Jpn J Oral Maxillofac Surg. 2012;58:297–301 (Japanese manuscript with English abstract).CrossRef Miyamoto S, Kaneko T, Sakaguchi W, Yasuda T, Chikazu D. A case of anti-BP180-type mucous membrane pemphigoid difficult to distinguish from bullous pemphigoid. Jpn J Oral Maxillofac Surg. 2012;58:297–301 (Japanese manuscript with English abstract).CrossRef
8.
Zurück zum Zitat Takada A, Hanaue N, Morisaki S, Morimoto M, Tanaka Y, Yamane G. A case of mucous membrane pemphigoid associated with myelodysplastic syndrome. Jpn J Oral Maxillofac Surg. 2008;54:20–4 (Japanese manuscript with English abstract).CrossRef Takada A, Hanaue N, Morisaki S, Morimoto M, Tanaka Y, Yamane G. A case of mucous membrane pemphigoid associated with myelodysplastic syndrome. Jpn J Oral Maxillofac Surg. 2008;54:20–4 (Japanese manuscript with English abstract).CrossRef
10.
Zurück zum Zitat Zenzo GD, Carrozzo M, Chan LS. Urban legend series: mucous membrane pemphigoid. Oral Dis. 2014;20:35–54.PubMedCrossRef Zenzo GD, Carrozzo M, Chan LS. Urban legend series: mucous membrane pemphigoid. Oral Dis. 2014;20:35–54.PubMedCrossRef
11.
Zurück zum Zitat Egan CA, Lazarova Z, Darling TN, Yee C, Coté T, Yancey KB. Anti-epiligrin cicatricial pemphigoid and relative risk for cancer. Lancet. 2001;357:1850–1.PubMedCrossRef Egan CA, Lazarova Z, Darling TN, Yee C, Coté T, Yancey KB. Anti-epiligrin cicatricial pemphigoid and relative risk for cancer. Lancet. 2001;357:1850–1.PubMedCrossRef
12.
Zurück zum Zitat Gately LE III, Nesbitt LT Jr. Update on immunofluorescent testing in bullous diseases and lupus erythematosus. Dermatol Clin. 1994;12:133–42.PubMedCrossRef Gately LE III, Nesbitt LT Jr. Update on immunofluorescent testing in bullous diseases and lupus erythematosus. Dermatol Clin. 1994;12:133–42.PubMedCrossRef
13.
Zurück zum Zitat Knudson RM, Kalaaji AN, Bruce AJ. The management of mucous membrane pemphigoid and pemphigus. Dermatol Ther. 2010;23:268–80.PubMedCrossRef Knudson RM, Kalaaji AN, Bruce AJ. The management of mucous membrane pemphigoid and pemphigus. Dermatol Ther. 2010;23:268–80.PubMedCrossRef
Metadaten
Titel
Anti-BP180-type mucous membrane pemphigoid: report of two cases
verfasst von
Mayumi Wada
Jun Sato
Masanobu Shindoh
Hideyuki Ujiie
Ken Natsuga
Wataru Nishie
Hiroshi Shimizu
Yoshimasa Kitagawa
Publikationsdatum
01.01.2016
Verlag
Springer Japan
Erschienen in
Odontology / Ausgabe 1/2016
Print ISSN: 1618-1247
Elektronische ISSN: 1618-1255
DOI
https://doi.org/10.1007/s10266-014-0181-2

Weitere Artikel der Ausgabe 1/2016

Odontology 1/2016 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update Zahnmedizin

Bestellen Sie unseren kostenlosen Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.